Overview

Phase IV Clinical Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye.

Status:
Not yet recruiting

Trial end date:
2021-11-30

Target enrollment:

Participant gender:

Summary

Phase IV, non inferiority, controlled, open, multicenter clinical study to compare the efficacy of the Ophthalmic Solution Humylub Ofteno® PF against Hyabak® and Lagricel Ofteno® PF applied quater in die (QID) for 30 days in patients with mild to moderate dry eye disease.

Phase:

Phase 4

Details

Lead Sponsor:

Laboratorios Sophia S.A de C.V.

Treatments:

Hyaluronic Acid